(Q37994540)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426368%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

title

Bexsero: a multicomponent vaccine for prevention of meningococcal disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426368%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426368%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

author name string

Rolando Pajón

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426368%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

publication date

1 February 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426368%20AND%20SRC:MED&resulttype=core&format=json

Human Vaccines & Immunotherapeutics

26 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426368%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426368%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426368%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

page(s)

174-183

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426368%20AND%20SRC:MED&resulttype=core&format=json

Global epidemiology of meningococcal disease.

26 January 2020

cites work

1 reference

Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity

21 January 2018

1 reference

Immunologic response of man to group B meningococcal polysaccharide vaccines.

21 January 2018

1 reference

Clinical evaluation of a group B meningococcal N-propionylated polysaccharide conjugate vaccine in adult, male volunteers.

21 January 2018

1 reference

21 January 2018

1 reference

Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil

21 January 2018

1 reference

Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease

21 January 2018

1 reference

From secondary prevention to primary prevention: a unique strategy that gives hope to a country ravaged by meningococcal disease

21 January 2018

1 reference

Use of an observational cohort study to estimate the effectiveness of the New Zealand group B meningococcal vaccine in children aged under 5 years

21 January 2018

1 reference

Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (PorA) outer membrane proteins.

21 January 2018

1 reference

Prevention of meningococcal serogroup B infections in children: a protein-based vaccine induces immunologic memory.

21 January 2018

1 reference

Epidemiology of meningococcal disease in England and Wales 1993/94 to 2003/04: contribution and experiences of the Meningococcal Reference Unit.

21 January 2018

1 reference

Three doses of an experimental detoxified L3-derived lipooligosaccharide meningococcal vaccine offer good safety but low immunogenicity in healthy young adults

21 January 2018

1 reference

A phase 1 study of a meningococcal native outer membrane vesicle vaccine made from a group B strain with deleted lpxL1 and synX, over-expressed factor H binding protein, two PorAs and stabilized OpcA expression.

21 January 2018

1 reference

Complete Genome Sequence of Neisseria meningitidis Serogroup B Strain MC58

21 January 2018

1 reference

Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.

21 January 2018

1 reference

A universal vaccine for serogroup B meningococcus

21 January 2018

1 reference

Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans

21 January 2018

1 reference

Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates

21 January 2018

1 reference

The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance

21 January 2018

1 reference

Vaccine potential of the Neisseria meningitidis 2086 lipoprotein

21 January 2018

1 reference

Immunogenicity and reactogenicity of a 13-valent-pneumococcal conjugate vaccine administered at 2, 4, and 12 months of age: a double-blind randomized active-controlled trial

21 January 2018

1 reference

Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines

21 January 2018

1 reference

Antibody persistence following MeNZB vaccination of adults and children and response to a fourth dose in toddlers.

21 January 2018

1 reference

Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination.

21 January 2018

1 reference

Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs.

21 January 2018

1 reference

Meningococcal genetic variation mechanisms viewed through comparative analysis of serogroup C strain FAM18.

21 January 2018

1 reference

NadA diversity and carriage in Neisseria meningitidis

21 January 2018

1 reference

Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcus

21 January 2018

1 reference

Frequency of factor H-binding protein modular groups and susceptibility to cross-reactive bactericidal activity in invasive meningococcal isolates

21 January 2018

1 reference

Characterization of fHbp, nhba (gna2132), nadA, porA, and sequence type in group B meningococcal case isolates collected in England and Wales during January 2008 and potential coverage of an investigational group B meningococcal vaccine

21 January 2018

1 reference

Characterization of Neisseria meningitidis isolates that do not express the virulence factor and vaccine antigen factor H binding protein

21 January 2018

1 reference

Reverse vaccinology, a genome-based approach to vaccine development

21 January 2018

1 reference

Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870

21 January 2018

1 reference

The modular architecture of meningococcal factor H-binding protein

21 January 2018

1 reference

Sequence diversity of the factor H binding protein vaccine candidate in epidemiologically relevant strains of serogroup B Neisseria meningitidis

21 January 2018

1 reference

NadA, a novel vaccine candidate of Neisseria meningitidis

21 January 2018

1 reference

Neisseria meningitidis NadA is a new invasin which promotes bacterial adhesion to and penetration into human epithelial cells.

21 January 2018

1 reference

Antibody to genome-derived neisserial antigen 2132, a Neisseria meningitidis candidate vaccine, confers protection against bacteremia in the absence of complement-mediated bactericidal activity

21 January 2018

1 reference

Cooperative serum bactericidal activity between human antibodies to meningococcal factor H binding protein and neisserial heparin binding antigen.

21 January 2018

1 reference

Measuring antigen-specific bactericidal responses to a multicomponent vaccine against serogroup B meningococcus.

21 January 2018

1 reference

Prevalence of factor H-binding protein variants and NadA among meningococcal group B isolates from the United States: implications for the development of a multicomponent group B vaccine

21 January 2018

1 reference

Meningococcal factor H binding proteins in epidemic strains from Africa: implications for vaccine development

21 January 2018

1 reference

Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and haemophilus influenzae type b conjugate vaccine in healthy infants in the United Kingdom primed with a monovalent meningococcal serogroup C vacc

21 January 2018

1 reference

Fine antigenic specificity and cooperative bactericidal activity of monoclonal antibodies directed at the meningococcal vaccine candidate factor h-binding protein

21 January 2018

1 reference

A meningococcal factor H binding protein mutant that eliminates factor H binding enhances protective antibody responses to vaccination

21 January 2018

1 reference

Bactericidal antibody responses induced by meningococcal recombinant chimeric factor H-binding protein vaccines

21 January 2018

1 reference

Novel blocking human IgG directed against the pentapeptide repeat motifs of Neisseria meningitidis Lip/H.8 and Laz lipoproteins

21 January 2018

1 reference

Immunogenicity and safety of a multicomponent meningococcal serogroup B vaccine and a quadrivalent meningococcal CRM197 conjugate vaccine against serogroups A, C, W-135, and Y in adults who are at increased risk for occupational exposure to meningoc

21 January 2018

1 reference